Table 4.
Study ID | Number of participants | Time; pathway group (minutes) | Time; control group (minutes) | P value |
---|---|---|---|---|
Carstensen et al. 2007 [21] | P N=108, | MD=154 (IQR 120-233) | MD= 249 (IQR 184-405) | P<0.001 |
C N=193 | ||||
Bång et al. 2008 [23] | P N=115, | MD=184 | MD=238 | P<0.02 |
C N=66 | (IQR NR) | (IQR NR) | ||
Dorsch et al. 2008 [22] | P N=172 | MD=105 | MD=143 | P<0.001 |
C N=215 | (IQR NR) | (IQR NR) | ||
Majumder et al. 2011 [25] | P N=200 | MD=106 (IQR 91-132) | MD=130 (IQR 103-164) | p<0.005 |
C N=161 | ||||
Cheskes et al. 2011 [26] | P N=80 | MD=70 (IQR 24) | MD=107 (IQR 30) | P<0.001 |
C N=95 | ||||
Bagai et al. 2013a [27] | P N=1316 | MD=68 (IQR 54-85) | MD=88 (IQR 73-106) | P<0.001 |
C N=11265 | ||||
Bagai et al. 2013b [28] | P N=28 | MD=75 (IQR 59-93) | MD=90 (IQR 76-109) | P<0.001 |
C N=1401 |
N= Numbers.
P= Pathway.
C= Control.
MD= Median.
IQR= Interquartile range.
NR= Not reported.
Symptom onset to balloon time.